Journal article
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Abstract
The tumor suppressor p53 plays a critical role to preserve DNA fidelity from diverse insults through the regulation of cell-cycle checkpoints, DNA repair, senescence and apoptosis. The TP53 is the most frequently inactivated gene in human cancers. This leads to the production of mutant p53 proteins that loose wild-type p53 tumor suppression functions and concomitantly acquire new oncogenic properties among which deregulated cell proliferation, …
Authors
Blandino G; Di Agostino S
Journal
Journal of Experimental & Clinical Cancer Research, Vol. 37, No. 1,
Publisher
Springer Nature
Publication Date
December 2018
DOI
10.1186/s13046-018-0705-7
ISSN
0392-9078